This week, the Hydrogen Europe board elected Dr Sopna Sury as its new chair, effective from 26.04.2023. Dr Sury has been the Chief Operating Officer Hydrogen of RWE Generation SE since February 2021.
The proposal for a patent package should reduce fragmentation and ensure timely competition and more equitable access to medicines especially in emergencies.
On 24 May, the European Commission is set to propose an EU Retail Investment Strategy. This would be a good opportunity to ensure that financial markets work for the people.
The Socialists and Democrats in the European Parliament will join forces with our Polish social democratic party, Nowa Lewica, at an external group meeting taking place in Krakow from 2 to 5 May, 2023, to defend the rule of law and women’s rights – issues that go hand in hand and have been under attack by the PiS government.
Payments from the European budget should be possible only if the activities they finance respect: social rights, minimum wage, safety at work, occupational safety, health, work-life balance and organisation of working time.
With citizens struggling to cope with the increasing cost of living, S&D Parliamentary leaders are committing to building a fairer and more progressive Europe that improves people’s lives.
The International Council for Harmonisation (ICH) has initiated the process for a new guideline on bioequivalence requirements for the approval of medicines, which is an important milestone for global convergence. The EU Pharmaceutical Strategy for Europe can build on this to enable global generic medicine development which is needed for better access to medicines and security of supply.
The S&Ds welcome the long-awaited legislative proposals for the much-needed reform of the EU fiscal rules presented today by the European Commission. It is positive in that the proposals foresee more flexibility for strategic investments and allow for different member states' debt reduction paths.
